|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 55.7 TWD | -0.36% |
|
+10.08% | -4.30% |
TCM Biotech International Corp. reported earnings results for the half year ended June 30, 2023. For the half year, the company reported sales was TWD 465.23 million compared to TWD 372.96 million a year ago.
Net income was TWD 8.42 million compared to TWD 13.27 million a year ago. Basic earnings per share from continuing operations was TWD 0.1747 compared to TWD 0.2717 a year ago. Diluted earnings per share from continuing operations was TWD 0.1747 compared to TWD 0.2717 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -4.30% | 101M | |
| +25.83% | 661B | |
| +27.00% | 566B | |
| -6.76% | 352B | |
| +20.34% | 332B | |
| +3.00% | 283B | |
| +13.09% | 231B | |
| +5.46% | 200B | |
| -9.61% | 195B | |
| -6.26% | 145B |
TCM BIOTECH INTERNATIONAL CORP. 
